|
JAMA Cardiology |
Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation |
1 |
Yes |
12/21/2024 |
|
JAMA Oncology |
Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer - A US Nationwide Veterans Affairs Study |
1 |
Yes |
12/21/2024 |
|
JAMA Oncology |
Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer - A US Nationwide Veterans Affairs Study |
1 |
Yes |
12/21/2024 |
|
JAMA |
Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Comparison of Stress and Suicide-Related Behaviors Among Korean Youths Before and During the COVID-19 Pandemic |
1 |
Yes |
12/21/2024 |
|
JAMA Ophthalmology |
Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India |
1 |
Yes |
12/21/2024 |
|
JAMA |
Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19 - A Randomized Clinical Trial |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 PneumoniaA Randomized Clinical Trial |
1 |
Yes |
12/21/2024 |
|
JAMA |
Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood ScoresA Randomized Clinical Trial |
1 |
Yes |
12/21/2024 |
|
JAMA |
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases - A Randomized Clinical Trial |
1 |
Yes |
12/21/2024 |
|
JAMA Internal Medicine |
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients - A Randomized Clinical Trial |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021 |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Factors Associated With COVID-19 Vaccine Receipt by Health Care Personnel at a Major Academic Hospital During the First Months of Vaccine Availability |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis - A Systematic Review and Meta-analysis |
1 |
Yes |
12/21/2024 |
|
JAMA |
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Implementation of State Vaccine Incentive Lottery Programs and Uptake of COVID-19 Vaccinations in the United States |
1 |
Yes |
12/21/2024 |
|
JAMA Pediatrics |
Intention to Vaccinate Children Against COVID-19 Among Vaccinated and Unvaccinated US Parents |
1 |
Yes |
12/21/2024 |
|
JAMA Internal Medicine |
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Sociodemographic Characteristics, Comorbidities, and Mortality Among Persons Diagnosed With Tuberculosis and COVID-19 in Close Succession in California, 2020 |
1 |
Yes |
12/21/2024 |
